BioPlus Acquisition (BIOS) Short Interest Ratio & Short Volume

Short interest is the volume of BioPlus Acquisition shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 1,600 shares of BIOS short. 0.01% of BioPlus Acquisition's shares are currently sold short. Learn More on BioPlus Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of BioPlus Acquisition's floating shares are currently sold short.

BioPlus Acquisition saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 1,600 shares, a decrease of 36.0% from the previous total of 2,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

BioPlus Acquisition currently has issued a total of 19,370,000 shares. Some of BioPlus Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioPlus Acquisition currently has a public float of 27,310,000 shares.

0.01% of BioPlus Acquisition's shares are currently sold short. Here is how the short interest of companies in the industry of "holding & other investment offices" compare to BioPlus Acquisition: Enphys Acquisition Corp. (0.00%), Keen Vision Acquisition Co. (0.05%), Gores Holdings IX, Inc. (0.01%), SDCL EDGE Acquisition Co. (0.03%), Mountain & Co. I Acquisition Corp. (0.00%), CONX Corp. (0.49%), Burtech Acquisition Corp. (0.04%), Investcorp Europe Acquisition Corp I (0.09%), Andretti Acquisition Corp. (0.06%), Investcorp India Acquisition Corp (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($8.05 billion), T-Mobile US, Inc. ($3.94 billion), Charter Communications, Inc. ($3.77 billion), Occidental Petroleum Co. ($3.27 billion), Tractor Supply ($2.29 billion), Celsius Holdings, Inc. ($2.20 billion), Rivian Automotive, Inc. ($2.10 billion), Moderna, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($1.90 billion), and T. Rowe Price Group, Inc. ($1.90 billion). View all of the most shorted stocks.

Short selling BIOS is an investing strategy that aims to generate trading profit from BioPlus Acquisition as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioPlus Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOS, twice per month. The most recent reporting period available is September, 15 2023.